Search results
Results From The WOW.Com Content Network
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...
The cost of Rituxan can depend on factors such as where a person lives and the facility that they visit to receive the infusions. If a person has Original Medicare, they will need to pay the Part ...
Most biologics are injections so are not appropriate for use by someone with intense fear of needles. [4] A person with any infection should not use biologics. [4] Other contraindications for biologics include cancer, certain neurologic disorders, being pregnant or breastfeeding, history of heart failure, or history of tuberculosis. [4]
Since 2000, the therapeutic market for monoclonal antibodies has grown exponentially. In 2006, the "big 5" therapeutic antibodies on the market were bevacizumab, trastuzumab (both oncology), adalimumab, infliximab (both autoimmune and inflammatory disorders, 'AIID') and rituximab (oncology and
Trastuzumab is given by slow injection into a vein and injection just under the skin. [144] [147] Common side effects include fever, infection, cough, headache, trouble sleeping, and rash. [144] Other severe side effects include heart failure, allergic reactions, and lung disease. [144] Use during pregnancy may harm the baby. [137]
The treatment starts with an infusion of rituximab. This may be followed by an administration of indium-111 labeled ibritumomab tiuxetan ( 111 In replaces the 90 Y component) to allow the distribution of the medication to be imaged on a gamma camera , before the actual therapy is administered.
IDOC last month disclosed that prison officials had secured lethal injection drugs for the first time in years when they also announced a death warrant for the 73-year-old Creech, a convicted ...
This regimen can also be combined with the monoclonal antibody rituximab if the lymphoma is of B cell origin; this combination is called R-CHOP. In 2002, a randomized controlled trial showed a higher complete response rate for R-CHOP vs CHOP in elderly patients with Diffuse Large-B-Cell Lymphoma (76% vs 63%). [ 4 ]